Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 530845 | NSE Symbol : | ISIN : INE199E01014 | Industry : Chemicals |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
13-Mar-2025	13-Mar-2025	Change in Directors	Please find attached outcome of board meeting held on 13 March 2025. Please find attached announcement of appointment of Director.
01-Feb-2025	11-Feb-2025	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Unaudited Financial Results for the quarter and nine-months ended 31 December 2024. Please find attached unaudited financials results for the quarter and nine-months ended 31 December 2024. (As Per BSE Announcement Dated on: 11/02/2025)
18-Oct-2024	28-Oct-2024	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the quarter and half-year ended 30th September 2024. Approval of Unaudited Results for quarter and half-year ended 30 September 2024 (As Per BSE Announcement Dated on 28.10.2024)
01-Aug-2024	09-Aug-2024	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/08/2024 inter alia to consider and approve unaudited financial results for the quarter ended 30 June 2024. The Board of Directors of the Company at its meeting held today, inter alia, has considered and approved the following: a) The Unaudited Financial Results of the Company for the quarter ended 30th June 2024. The Auditors have issued an unmodified report. b) Raising of funds through the issuance of equity shares by way of rights issue for an amount not exceeding Rs. 200 crores. c) Constitution of 'Rights Issue Committee' for dealing with and deciding all matters pertaining to the proposed rights issue; and d) Purchase of land from Mr. Jeet Malhotra, Managing Director & CEO of the Company for expansion of business of the Company Designating Dr. Maya Parihar Malhotra as Chairperson effective from 16 August 2024. (As Per BSE Announcement dated on 09.08.2024)
07-May-2024	16-May-2024	Accounts	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2024 inter alia to consider and approve 1. the audited financial results and financial statements of the company for the quarter and financial year ended 31st March 2024. 2. recommend final dividend if any for the financial year ended 31st March 2024. Financial Results and Dividend Accouchement (As Per BSE Announcement dated on 16.05.2024)
31-Jan-2024	09-Feb-2024	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine-months ended 31st December 2023. Further in continuation of our intimation on closure of trading window on 27th December 2023 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 11th February 2024. Board of Directors at its meeting held on 9 February 2024 have approved interim dividend of Rs. 1.20 per Equity Share of Rs. 10/- each. The Board of Directors at its Meeting held on 9th February 2024 approved the following: 1. Unaudited Financial Results of the Company for quarter and nine-months ended 31st December 2023. 2. Declaration of Interim Dividend of Rs. 1.20/- per equity share of Rs. 10/- each for the financial year 2023-2024. Accordingly, the Board has fixed Thursday, 22nd February 2024 as a record date for determining entitlement of members for the purpose of payment of interim dividend. (As Per BSE Announcement Dated on 09.02.2024)
20-Oct-2023	01-Nov-2023	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2023 inter alia to consider and approve unaudited financial results for the quarter and half-year ended 30 September 2023. Trading window will remain close till 3 November 2023. Financial Results and Limited Review Report for the quarter and half year ended 30 September 2023 attached. (As Per BSE Announcement Dated on 01/11/2023)
25-Jul-2023	11-Aug-2023	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2023 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30 June 2023. Trading window will remain close till 13 August 2023. SUNSHIELD CHEMICALS LIMITED has informed BSE about Board Meeting to be held on 11 Aug 2023 to consider financial statements for the period ended June 2023. Financial results. Please find attached approved results for June 2023 quarter and limited review report. Please find attached approved results for June 2023 quarter and limited review report. Disclosure under Regulation 30 read with Schedule III Part A Para B Clause 3 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated on 11.08.2023)
08-May-2023	16-May-2023	Accounts	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/05/2023 inter alia to consider and approve 1. To consider and approve the audited financial results and financial statements of the company for the quarter and financial year ended 31st March 2023. 2. To consider and recommend final dividend if any for the financial year ended 31st March 2023. Further in continuation of our intimation on closure of trading window on 29th March 2023 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 18th May 2023. Board at its meeting have approved: 1. Audited Financial Results for the quarter and year ended 31st March 2023. Copy of financial results along with Auditors Report issued by CNK & Associates LLP, Statutory Auditor of the Company are enclosed. The aforesaid Auditor's Report for the period ended 31st March 2023, is with unmodified opinion. 2. Recommendation of payment of final dividend @ Rs. 2/- per equity share of the face value of Rs.10/- each for the financial year ended 31st March 2023, subject to approval of shareholders at the ensuing 36th Annual General Meeting ('AGM'). 3. Recommendation of appointment of M/s. CNK & Associates LLP, Chartered Accountants (Firm Registration No 101961W/W100036) as Statutory Auditor, for a period of 5 years. The Board of Directors of the Company at its meeting held today which commenced at inter-alia, have recommended appointment of M/s. CNK & Associates LLP, Chartered Accountants (Firm Registration No 101961W/W100036) as Statutory Auditor, for a period of 5 years, to hold office from the conclusion of forthcoming Annual General Meeting ('AGM') till the conclusion of the forty-first AGM to be held in the year 2028. The intimation pursuant to the requirements of the SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September 2015, is enclosed herewith as Annexure -A. The appointment is subject to approval of Members in the forthcoming AGM. (As Per BSE Announcement Dated on 16.05.2023)
23-Jan-2023	03-Feb-2023	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/02/2023 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine-months ended 31st December 2022. Further in continuation of our intimation on closure of trading window on 28th December 2022 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 5th February 2023. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015 and based on recommendation of Nomination and Remuneration Committee, the Board of Directors at their meeting held on 3rd February 2023 have considered and approved: 1. Redesignation of Mr. Jeet Malhotra, Director & CEO as Managing Director & CEO, effective from 3rd February 2023. All other terms and conditions of his appointment, as approved by the shareholders on 28th March 2022 vide Postal Ballot shall remain unchanged. (Profile of Mr. Jeet Malhotra has already been shared vide letter dt. 30th November 2021). The Company will be seeking approval of the shareholders through Postal Ballot. We request you to kindly take the above information on record. Kindly acknowledge the receipt. The Board of Directors at its Meeting held on 3rd February 2023 has approved and have taken on record the Unaudited Financial Results of the Company for quarter and nine months ended 31st December 2022 as recommended by Audit Committee. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, please find enclosed the following: 1. Unaudited Financial Results of the Company for quarter and nine months ended 31st December 2022. 2. Limited Review Report issued by M/s. CNK & Associates LLP, Chartered Accountants, Statutory Auditor in respect of the unaudited Financial Results for the quarter and nine months ended 31st December 2022. The Auditors have issued unmodified report. The Board Meeting started at 11.40 a.m. and concluded at 12.30 p.m. (As per BSE Announcement Dated on 03/02/2023)
02-Nov-2022	11-Nov-2022	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2022 inter alia to consider and approve to consider and take on record the Unaudited Financial Results for the quarter and half-year ended 30th September 2022. Further in continuation of our intimation on closure of trading window on 28th September 2022 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 13th November 2022. The Board of Directors at its Meeting held on 11th November 2022 has approved and have taken on record the Unaudited Financial Results of the Company for quarter and half year ended 30th September 2022 as recommended by Audit Committee. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, please find enclosed the following: 1. Unaudited Financial Results of the Company for quarter and half year ended 30th September 2022. 2. Limited Review Report issued by M/s. CNK & Associates LLP, Chartered Accountants, Statutory Auditor in respect of the unaudited Financial Results for the quarter and half year ended 30th September 2022. The Auditors have issued unmodified report. The Board Meeting started at 11.31 a.m. and concluded at 12.40 p.m. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015 and based on recommendation of Nomination and Remuneration Committee and Audit Committee of the Company, the Board of Directors at their meeting held on 11th November 2022 have considered and approved appointment of Mr. Aashish Agarwaal as Chief Financial officer (CFO) of the Company effective from 11th November 2022. Mr. Aashish Agarwaal is designated as Key Managerial Personnel (KMP) of the Company. Brief Profile of Mr. Aashish Agarwaal and details required under regulation 30 of Listing Regulations read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated 9th September 2015 are given in Annexure-A. We request you to kindly take the above information on record. (As Per BSE Announcement dated on 11.11.2022)
01-Aug-2022	13-Aug-2022	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2022 inter alia to consider and approve Unaudited Financial Results for the quarter ended 30th June 2022. Further in continuation of our intimation on closure of trading window on 27th June 2022 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 15th August 2022. The Board of Directors at its Meeting held on 13th August 2022 has approved and have taken on record the Unaudited Financial Results of the Company for quarter ended 30th June 2022 as recommended by Audit Committee. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, please find enclosed the following: Unaudited Financial Results of the Company for quarter ended 30th June 2022. Limited Review Report issued by M/s. CNK & Associates LLP, Chartered Accountants, Statutory Auditor in respect of the unaudited Financial Results for the quarter ended 30th June 2022. The Auditors have issued unmodified report. The Board Meeting started at 11.15 a.m. and concluded at 11.45 a.m. Kindly acknowledge the receipt. (As Per BSE Announcement Dated on 13/08/2022)
27-Jun-2022	27-Jun-2022	Change in Auditors	This has reference to our letter dated 17th June 2022 intimating about the resignation by the M/s. Deloitte Haskins & Sells LLP, Chartered Accountants as Statutory Auditors of the Company. We wish to inform that the Board of Directors of the Company, on the recommendation of the Audit Committee, have today appointed M/s. CNK, Chartered Accountants (ICAI Firm Registration No. 101961W /W100036), as Statutory Auditors of the Company in the casual vacancy caused by the aforesaid resignation. The said appointment will be placed for shareholders' approval at the ensuing Annual General Meeting. Details with respect to resignation/ change in Auditors of the Company as required under Regulation 30 Read with Schedule Ill of the Listing Regulations, SEBI Circular CIR/CFD/CMD/4/2015 dated September 09, 2015 and CIR/CFD/CMD1/114/2019 dated October 18, 2019 are annexed herewith.
19-May-2022	30-May-2022	Accounts	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2022 inter alia to consider and approve Audited Financial Results for the quarter and year ended 31st March 2022. Further in continuation of our intimation on closure of trading window on 31st March 2022 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 1st June 2022. This is further to our letter dated 19th May 2022 intimating that the Board Meeting of the Company is scheduled on 30th May 2022 inter alia, to consider and approve Audited Financial Results of the Company for the quarter and year ended 31* March 2022. Pursuant to Regulation 29(1) & 29(2) of SEBI (Listing Obligations & Disclosure Requirements), Regulations 2015, it is further intimated that the Board of Directors of the Company may consider declaration of dividend for the financial year 2021-22 at the aforesaid Board Meeting. The above is for your information and record please. (As Per BSE Announcement Dated on 25-05-2022) Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, the Board of Directors at their meeting held on 30 May 2022 have recommended the dividend of Rs. 2/- (Rupees two only) per equity share of the face value of 10/- (Rupees ten only) for the financial year 2021-22, subject to approval of the members at the ensuing Annual General Meeting (AGM). The date of AGM and book closure for the purpose of payment of dividend will be announced in due course. The Board of Directors at its Meeting held on 30th May 2022 has approved and have taken on record the Audited Financial Results of the Company for year ended 31st March 2022 as recommended by Audit Committee. We hereby declare that the Statutory Auditors' of the Company Deloitte Haskins & Sells LLP, Chartered Accountants, Mumbai have issued Audit Reports with unmodified opinion on the Audited Financial Results of the Company for year ended on 31st March 2022. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, the Board of Directors have recommended the dividend of Rs. 2/- (Rupees two only) per equity share of the face value of 10/- (Rupees ten only) for the financial year 2021-22, subject to approval of the members at the ensuing Annual General Meeting (AGM). The date of AGM and book closure for the purpose of payment of dividend will be announced in due course. The Board Meeting started at 11.40 a.m. and concluded at 12.41 p.m. (As Per BSE Announcement Dated on 30-05-2022)
31-Jan-2022	14-Feb-2022	Quarterly Results	SUNSHIELD CHEMICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2022 inter alia to consider and approve Unaudited Financial Results for the quarter and nine months ended 31st December 2021. Further in continuation of our intimation on closure of trading window on 28th December 2021 and pursuant to the provisions of SEBI (Prohibition of Insider Trading) Regulations 2015 the trading window for dealing in the securities of the Company shall remain closed for all designated persons and their immediate relatives till 16th February 2022. The Board of Directors at its Meeting held on 14th February 2022 has approved and have taken on record the Unaudited Financial Results of the Company for quarter and nine months ended 31st December 2021 as recommended by Audit Committee. Pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulation 2015, please find enclosed the following: 1. Unaudited Financial Results of the Company for quarter and nine months ended 31st December 2021. 2. Limited Review Report issued by M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditor in respect of the unaudited Financial Results for the quarter and nine months ended 31st December 2021. The report does not have UDIN number due to technical issues. The report with UDIN number will be updated subsequently. The Board Meeting started at 11.45 a.m. and concluded at 12.40 p.m. Kindly acknowledge the receipt. (As Per BSE Announcement Dated 14.02.2022)

1 2

LOGIN HERE

Sunshield Chemicals Ltd

Board Meeting